SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001654954-22-005221
Filing Date
2022-04-21
Accepted
2022-04-20 18:05:16
Documents
73
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM - 10Q/A zivo_10qa.htm   iXBRL 10-Q/A 1248796
2 CERTIFICCATION zivo_ex311.htm EX-31.1 13649
3 CERTIFICCATION zivo_ex312.htm EX-31.2 13490
4 CERTIFICCATION zivo_ex321.htm EX-32.1 4504
5 CERTIFICCATION zivo_ex322.htm EX-32.2 4621
  Complete submission text file 0001654954-22-005221.txt   6761408

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bion-20210930.xsd EX-101.SCH 77809
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bion-20210930_lab.xml EX-101.LAB 380562
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bion-20210930_cal.xml EX-101.CAL 49799
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bion-20210930_pre.xml EX-101.PRE 342197
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bion-20210930_def.xml EX-101.DEF 228506
67 EXTRACTED XBRL INSTANCE DOCUMENT zivo_10qa_htm.xml XML 1215045
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Filer) CIK: 0001101026 (see all company filings)

IRS No.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-40449 | Film No.: 22839196
SIC: 2836 Biological Products, (No Diagnostic Substances)